Jun Seok Park1,2, Hyun Kang3, Soo Yeun Park1, Hye Jin Kim1, In Teak Woo1,3,2, In-Kyu Park1, Gyu-Seog Choi4,5. 1. Colorectal Cancer Center, School of Medicine, Kyungpook National University Medical Center, Kyungpook National University, Daegu, South Korea. 2. Kyungpook National University Bio-Medical Research Institute, Daegu, South Korea. 3. Departments of Anesthesiology and Pain Medicine, College of Medicine, Chung-Ang University, Seoul, South Korea. 4. Colorectal Cancer Center, School of Medicine, Kyungpook National University Medical Center, Kyungpook National University, Daegu, South Korea. kyuschoi@mail.knu.ac.kr. 5. Department of Surgery, Colorectal Cancer Center, School of Medicine, Kyungpook National University Medical Center, Kyungpook National University, 807, Hogukno, Buk-gu, 702-210, Daegu, South Korea. kyuschoi@mail.knu.ac.kr.
Abstract
OBJECTIVE: The aim of this study was to compare the long-term outcomes of robot-assisted right colectomy (RAC) with those for conventional laparoscopy-assisted right surgery (LAC) for treating right-sided colon cancer. BACKGROUND: The enthusiasm for the robotic techniques has gained increasing interest in colorectal malignancies. However, the role of robotic surgery in the oncologic safety has not yet been defined. METHODS:From September 2009 to July 2011, 71 patients with right-sided colonic cancer were randomized in the study. Adjuvant therapy and postoperative follow-up were similar in both groups. The primary and secondary endpoints of the study were hospital stay and survival, respectively. Data were analyzed by intention-to-treat principle. RESULTS: The RAC and LAC groups did not differ significantly in terms of baseline clinical characteristics. Compared with the LAC group, RAC was associated with longer operation times (195 min vs. 129 min, P < 0.001) and higher cost ($12,235 vs. $10,319, P = 0.013). The median follow-up was 49.23 months (interquartile range 40.63-56.20). The combined 5-year disease-free rate for all tumor stages was 77.4% (95% confidence interval [CI], 60.6-92.1%) in the RAC group and 83.6% (95% CI 72.1-0.97.0%) in the LAC group (P = 0.442). The combined 5-year overall survival rates for all stages were 91.1% (95% CI 78.8-100%) in the RAC group and 91.0% (95% CI 81.3-100%) in the LAC group (P = 0.678). Using multivariate analysis, RAC was not a predictor of recurrence. CONCLUSIONS:RAC appears to similar long-term survival as compared with LAC. However, we did not observe any clinical benefits of RAC which could translate to a decrease in expenditures. TRIAL REGISTRY: http://www.ClinicalTrials.gov , number NCT00470951.
RCT Entities:
OBJECTIVE: The aim of this study was to compare the long-term outcomes of robot-assisted right colectomy (RAC) with those for conventional laparoscopy-assisted right surgery (LAC) for treating right-sided colon cancer. BACKGROUND: The enthusiasm for the robotic techniques has gained increasing interest in colorectal malignancies. However, the role of robotic surgery in the oncologic safety has not yet been defined. METHODS: From September 2009 to July 2011, 71 patients with right-sided colonic cancer were randomized in the study. Adjuvant therapy and postoperative follow-up were similar in both groups. The primary and secondary endpoints of the study were hospital stay and survival, respectively. Data were analyzed by intention-to-treat principle. RESULTS: The RAC and LAC groups did not differ significantly in terms of baseline clinical characteristics. Compared with the LAC group, RAC was associated with longer operation times (195 min vs. 129 min, P < 0.001) and higher cost ($12,235 vs. $10,319, P = 0.013). The median follow-up was 49.23 months (interquartile range 40.63-56.20). The combined 5-year disease-free rate for all tumor stages was 77.4% (95% confidence interval [CI], 60.6-92.1%) in the RAC group and 83.6% (95% CI 72.1-0.97.0%) in the LAC group (P = 0.442). The combined 5-year overall survival rates for all stages were 91.1% (95% CI 78.8-100%) in the RAC group and 91.0% (95% CI 81.3-100%) in the LAC group (P = 0.678). Using multivariate analysis, RAC was not a predictor of recurrence. CONCLUSIONS: RAC appears to similar long-term survival as compared with LAC. However, we did not observe any clinical benefits of RAC which could translate to a decrease in expenditures. TRIAL REGISTRY: http://www.ClinicalTrials.gov , number NCT00470951.
Entities:
Keywords:
Laparoscopy; Right colon; Robotic surgery; Survival
Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman Journal: Int J Surg Date: 2011-10-12 Impact factor: 6.071
Authors: Peter Tschann; Markus P Weigl; Daniel Lechner; Christa Mittelberger; Tarkan Jäger; Ricarda Gruber; Paolo N C Girotti; Christof Mittermair; Patrick Clemens; Christian Attenberger; Philipp Szeverinski; Thomas Brock; Jürgen Frick; Klaus Emmanuel; Ingmar Königsrainer; Jaroslav Presl Journal: Cancers (Basel) Date: 2022-06-30 Impact factor: 6.575
Authors: Peter Tschann; Philipp Szeverinski; Markus P Weigl; Stephanie Rauch; Daniel Lechner; Stephanie Adler; Paolo N C Girotti; Patrick Clemens; Veronika Tschann; Jaroslav Presl; Philipp Schredl; Christof Mittermair; Tarkan Jäger; Klaus Emmanuel; Ingmar Königsrainer Journal: J Clin Med Date: 2022-04-24 Impact factor: 4.964
Authors: Chetna Ravindra; Emmanuelar O Igweonu-Nwakile; Safina Ali; Salomi Paul; Shreyas Yakkali; Sneha Teresa Selvin; Sonu Thomas; Viktoriya Bikeyeva; Ahmed Abdullah; Aleksandra Radivojevic; Anas A Abu Jad; Anvesh Ravanavena; Prachi Balani Journal: Cureus Date: 2022-07-19